What Happened?
Philadelphia, PA-based Spirovant Appointed Eric Pastor as Senior Vice President of Technical Development and Operations
About the Company
Spirovant is a gene therapy company focused on changing the course of cystic fibrosis and other respiratory diseases. The company`s current investigational gene therapy technologies are designed to overcome the historical barriers that have prevented effective genetic treatments for cystic fibrosis. Spirovant`s lead programs are in development for cystic fibrosis. Spirovant is a wholly owned subsidiary of Sumitovant Biopharma Ltd., which is itself a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Spirovant is located in Philadelphia, PA.
About the Person
Eric Pastor is Senior Vice President of Technical Development and Operations at Spirovant. Previously, Eric held various senior IT leadership roles in the industry.
Info Source
News
Short Profile